Healthcare stocks came under pressure after Novo Nordisk (NYSE:NVO) warned that it expects a steep decline in annual sales, sending its U.S.–listed shares slumping nearly 15%, exacerbating losses in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results